Medical Health & Life Science Research News

Research delivers insight into the leukemia diagnostic tests market

Medical Market Research

GlobalData's Medical Devices sector report, “Leukemia Diagnostic Tests Medical Devices Pipeline Assessment, 2017" provides an overview of Leukemia Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development.

It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Leukemia Diagnostic Tests pipeline products.

Report: orbisresearch.com/contacts/request-sample/328997 

Companies Mentioned:
Acobiom
Aegis Sciences Corp
BioSense Technologies, Inc.
Cancer Genetics Inc
Cell2in
CeMines, Inc.
Cepheid
Di.V.A.L Toscana srl 
DiaSorin S.p.A
Eutropics Pharmaceuticals Inc
H. Lee Moffitt Cancer Center & Research Institute Inc
Health Discovery Corp
IV Diagnostics, Inc.
Jaden BioScience Inc.
King's College London
Microfluidic Innovations LLC
Monoquant Pty. Ltd.
Nodality Inc
NuCana BioMed Ltd
Nuclea Biotechnologies Inc.
OncoVista Innovative Therapies Inc
Roche Diagnostics International Ltd
Siemens Healthcare GmbH
SkylineDx BV
St. Jude Children’s Research Hospital Inc
Stanford University
The Feinstein Institute for Medical Research
Treos Bio Inc
University of Bergen
University of California San Diego
University of Colorado
University of Missouri
University of Pennsylvania
Vela Diagnostics Pte. Ltd
Vivia Biotech SL
Wake Forest Baptist Medical Center

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Browse the complete report at orbisresearch.com/reports/index/le…e-assessment-2017 

Scope
Extensive coverage of the Leukemia Diagnostic Tests under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Leukemia Diagnostic Tests and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to access
The report enables you to
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Leukemia Diagnostic Tests under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

Report: orbisresearch.com/contacts/328997 

News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany about: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...
This email address is being protected from spambots. You need JavaScript enabled to view it.